The Timeline: Cutting the Cord
The road to the January 22nd exit began on January 20, 2025, when President Trump signed Executive Order 14155 on his first day in office. The order gave the WHO the required one-year notice, citing a “systemic failure to protect American interests” and a “lethal lack of transparency” regarding the origins of COVID-19.
The administration’s logic was simple: The WHO’s incompetence during the pandemic cost the U.S. economy between $14 trillion and $16 trillion. To pay more into a system that failed so spectacularly would be “economic malpractice.” By the time the clock ran out yesterday, the U.S. refused to pay a final $278 million in outstanding dues, arguing that the American people had already paid “more than enough” in lives and lost wages.
They always say “Follow the Money”
When the U.S. donates to the WHO for “health system strengthening,” that money often goes toward paying the salaries and administrative costs of foreign health ministries.
-
The 30% Overhead: WHO’s own studies have admitted that roughly 30% of its expenditure goes toward “Administration and Management” (A&M). This includes travel, luxury hotels for representatives, and the “Strategic Objectives” of regional offices.
-
Foreign Payrolls: In many developing nations, the WHO effectively funds the “Ministry of Health” through grants. American taxpayers are essentially paying the salaries of government officials in Ethiopia, Yemen, and Afghanistan under the guise of “technical cooperation.”
The “Surveillance” Rebuttal: Fear-Mongering over Flu
The minute the exit became official, the WHO and organizations like the IDSA (Infectious Diseases Society of America) released a flurry of warnings. Their primary claim? Without the WHO, the U.S. is “out of the loop” on the latest flu strains and global pandemics. They argue that by leaving the Global Influenza Surveillance and Response System (GISRS), we won’t have the data needed to make yearly flu shots.
But here’s the reality they won’t tell you: Why is the American taxpayer doing the R&D for multi-billion dollar drug companies? If a pharmaceutical company wants to sell a flu shot for $50 a dose, shouldn’t it be their job to stay on top of the science? In any other industry, a company that relies on the government to do its basic research while keeping 100% of the profits would be called a “subsidy queen.” In the drug world, they call it “public health.”
The “Double Pay” and the Legal Shield
American taxpayers are “paying twice” for every vaccine on the market.
-
Payment #1: We fund the NIH and the CDC to do the “basic research” and the surveillance that identifies the strains.
-
Payment #2: We pay the pharmaceutical companies top-dollar for the finished product.
To make matters worse, these companies have no financial incentive to produce a high-quality product because they are immune from lawsuits. Under the National Childhood Vaccine Injury Act of 1986, you cannot sue a vaccine maker for most injuries. Instead, a $0.75 excise tax paid by the consumer goes into a “Trust Fund” that pays out for injuries. We pay for the research, we pay for the drug, and we pay for the damages when the drug fails.
Watch how this plays out
The FDA doesn’t actually test if one flu shot is “better” than another before approving it. They only test if it’s “good enough” on its own.
In a normal market, if you make a product that performs worse than your competitor’s, you go out of business. But the flu vaccine market is a protected monopoly where the government has removed the usual “fail” triggers.
Here is the line-by-line breakdown of how a drug company can get away with a low-quality product while competitors do better.
1. The “Non-Inferiority” Loophole
When a drug company submits a new flu vaccine for approval, the FDA doesn’t ask, “Is this the best vaccine on the market?” They ask, “Is this vaccine ‘non-inferior’ to what we already have?”
-
The Standard: As long as the vaccine produces a certain level of antibodies in a test tube (a “surrogate endpoint”), it passes.
-
The Reality: A vaccine can be 10% or 20% less effective in the real world than a competitor’s, but as long as it hits that antibody “floor,” it gets the FDA stamp of approval.
2. The “Strain Change” Rule (Minimal Testing)
Because the flu changes every year, the FDA allows manufacturers to make “tweaks” to their recipe without running new, large-scale clinical trials.
-
The Shortcut: Companies simply swap out the old virus strain for the new one recommended by the government.
-
The Result: Since there is no annual head-to-head trial comparing Brand A to Brand B, a company can produce a “match” that is technically correct but biologically weaker (e.g., egg-based vs. cell-based) and no one knows until the season is already over.
3. The Egg-Based Failure (The $0.75 Subsidy)
Most flu shots are still grown in chicken eggs because it’s the cheapest, oldest way to do it.
-
The Glitch: Viruses often mutate inside the egg. This means by the time the shot gets to you, it might not even match the virus in the air anymore.
-
Why they keep doing it: Transitioning to better, “cell-based” or “recombinant” tech is expensive. Since the government guarantees the purchase and protects them from lawsuits (via that $0.75 tax we discussed), the companies have zero financial incentive to innovate or fix a low-quality egg-grown product.
4. No Market “Death” for Failures
In a real business, if a car’s brakes fail, the company is sued into oblivion. In the vaccine world:
-
The Shield: You cannot sue the company for “lack of efficacy.”
-
The Guaranteed Buyer: State and federal governments pre-purchase hundreds of millions of doses. If a company produces a “dud” year, they still get paid. The taxpayer eats the loss, and the company moves on to the next year’s contract.
Bottom line, as long as the drug companies release a new product that passes FDA, they make money whether it helps you or not, and if you sue them you are still paying for that settlement yourself, not them. Tell me this makes sense?
The China Connection: A Failed System
The WHO’s defenders say we need global cooperation. But if the system worked, COVID-19 wouldn’t have reached our shores. Even though the U.S. was the top donor and China was a member, Beijing systematically suppressed genetic data and human-to-human transmission evidence for weeks in early 2020.
The WHO didn’t challenge them; they repeated Beijing’s talking points, even calling U.S. travel bans “racist” while the virus was already spreading globally. If billions of dollars can’t buy transparency from a member state during a once-in-a-century crisis, then the “system” is a hollow shell.
While the U.S. was the top donor, the WHO proved it had no “teeth” to force China to be upfront.
-
The “No Human-to-Human” Myth: In January 2020, the WHO tweeted that Chinese authorities found “no clear evidence of human-to-human transmission,” even as doctors in Wuhan were being silenced for sounding the alarm.
-
The Data Blackout: It took over a year for a WHO team to even get into Wuhan. Once there, they were denied access to raw data on the earliest patients. Today, in 2026, we still don’t have the full genetic sequences from those first clusters because China continues to withhold them—despite the WHO’s “appeals.”
-
The Money Trap: Critics point out that while the U.S. paid more, China used its influence to ensure the WHO report in 2021 called a “lab leak” “extremely unlikely”—a conclusion the WHO director later had to walk back under pressure.
Why China Didn’t “Help” with Vaccines
You mentioned that China should have helped. Instead, they engaged in what is now called “Vaccine Diplomacy.”
-
Selling, Not Sharing: China didn’t give away their data to help make a global vaccine. They used their state-backed companies (Sinovac/Sinopharm) to sell vaccines to developing nations as a way to gain political leverage, often at higher prices than Western versions.
-
The Competitive Edge: They treated the pandemic as a race for global dominance. Sharing origin data might have revealed flaws in their biosafety protocols (the “lab leak” theory), so they chose to protect their reputation over providing the data needed for better global vaccines.
The Closed Loop: The Bill Gates Show
As we peel back the layers, we find that the “World” in World Health Organization is increasingly just a front for one man: Bill Gates.
-
The Money: With the U.S. out, the Bill & Melinda Gates Foundation (BMGF) is now the de-facto largest funder. Gates provides nearly 10% of the WHO’s total revenue.
-
The Conflict: Gates is a founding partner and major donor to Gavi, the Vaccine Alliance, which buys the drugs the WHO regulates. He also holds massive stakes in companies like Pfizer and BioNTech.
-
The Agenda: Gates doesn’t just give money; he earmarks it. 82% of his contributions to the WHO are directed toward his personal priorities—namely infectious diseases and vaccines—while basic health systems are ignored.
Closing: The America First Reality
For years, everyone hated Trump for wanting to pull out of the WHO. But he was the only one willing to look at the receipts. He saw a system where:
-
Taxpayers fund the research.
-
Drug Companies take the profits and the legal immunity.
-
Globalists like Bill Gates control the regulations and the agenda.
-
China hides the data.
By cutting the cord, Trump isn’t just saving billions; he’s breaking a closed-loop system of corporate welfare and ideological social engineering.
Q: Won’t the U.S. be vulnerable to new viruses without WHO data? A: No. The U.S. is shifting to Bilateral Surveillance. We are creating direct deals with 63 “trusted partner” nations. We give them aid; they give us direct, unfiltered access to their labs. No more waiting for Geneva to “approve” the truth.
Q: Who pays for vaccine injuries if we can’t sue the companies? A: You do. Every dose of a recommended vaccine includes a $0.75 tax that goes into the Vaccine Injury Compensation Trust Fund. It’s a “no-fault” system designed to protect drug companies from the consequences of their own manufacturing failures.
Q: Why is Bill Gates allowed to fund the WHO if he has a conflict of interest? A: Because the WHO is a “voluntary” organization. They take money from whoever gives it. With the U.S. gone, Gates has no “check” on his power. He is the funder, the investor, and the regulator all in one.
The “Demographic” Agenda
This leads us to the most disturbing layer: the population agenda. Bill Gates has famously stated that “if we do a great job on new vaccines… we could lower [population] by 10 or 15 percent.”
This isn’t just about vaccines; it’s about a massive $2.5 billion commitment through 2030 focused on “reproductive health.” In 2025, while the U.S. was cutting aid for global abortion advocates, Gates stepped in to fill the void. He and his ex-wife Melinda (who now has her own $1 billion fund) are using their wealth to promote a “health” agenda that prioritizes population control and global abortion access.
Let’s be clear: First of all, I’m not saying the governmet needs to have a say in what a woman does.However, abortion for the sake of birth control is not “women’s health” any more than killing a dog is “men’s health.” A separate life is a separate life. Yet, this billionaire-funded organization is using the UN logo to launder a “global genocide” agenda under the guise of “equity.” Are the Gates funding abortion as a way to reach their goal to lower the global population?
According to the latest data from the Charlotte Lozier Institute and state-level reporting (like Florida, Minnesota, and Nebraska), the vast majority of abortions are not for health crises.
| Reason Category | Percentage | Real-World Definition |
| Elective / Unspecified | 95% – 97% | Post-conception birth control, financial unreadiness, timing, or career goals. |
| Physical Health of Mother | 1% – 2% | Non-life-threatening physical issues (e.g., chronic back pain or diabetes management). |
| Life-Threatening Risk | 0.2% – 0.5% | Severe preeclampsia, cancer, or infection where the mother’s life is at risk. |
| Fetal Anomaly | 1% – 1.5% | Detection of genetic issues or physical deformities in the fetus. |
| Rape / Incest | 0.3% – 0.5% | Pregnancies resulting from criminal sexual assault. |
The “Birth Control” Layer: Why They Are Happening
The Guttmacher Institute—the research arm that supports abortion access—confirms that the decision is almost always social or financial. In their most recent comprehensive surveys:
-
74% of women stated that a child would interfere with their education, work, or ability to care for other dependents.
-
73% said they simply could not afford a baby at the time.
-
48% cited relationship problems or a desire not to be a single mother.
-
Approximately 51% of women obtaining an abortion were already using some form of contraception (condoms or the pill) during the month they became pregnant, meaning the abortion served as the “final stop” for failed birth control.
The “Women’s Health” Misnomer
When organizations like the WHO or Planned Parenthood talk about “Women’s Health,” they are grouping that 95% elective category in with the 0.3% life-saving category.
-
By labeling the entire industry as “health care,” they protect the billion-dollar profit center of elective procedures using the rare, tragic cases of life-threatening pregnancies as a moral shield.
Closing Statement
The “Bamboozle” is finally being exposed. We were told the WHO kept us safe; the 16 million dead from COVID-19 say otherwise. We were told drug companies need our help; their record-breaking profits say otherwise. The U.S. withdrawal is the first step in a world where American health is decided by American citizens, not billionaire board members in Geneva.
The numbers don’t lie. It’s time to stop the “Bill Gates Show” and put America First.
#WHOWithdrawal #BillGates #BigPharma #PublicHealth #AmericaFirst #TheNumbersDontLie #EricGilbert

